Black Diamond Therapeutics Inc at Stifel Healthcare Conference Transcript
(audio in progress) Therapeutics, the CEO there. We're going to do about a half-and-half situation here with a presentation from David, and then we'll sit down and do a fireside chat afterwards. So thanks, David, for joining, and take it away.
Thank you for the invite, and happy to represent Black Diamond today.
So all the important disclaimers. Just give a really quick intro to the company. So we're a next-gen precision medicine company, focusing on oncology and in MasterKey therapies. And what we do is we develop MasterKey therapies with the sole purpose of expanding the patient population available to targeted therapies. And we do this through the use of the development of these MasterKey inhibitors -- unfortunately, I can't -- won't be able to point.
So I'm going to tell you, first bullet point, MasterKey inhibitors target a family of mutations. And we do this simply because we're able to expand the patient population. But what's unique about
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
